# Olanzapine Anorexia Cachexia

> **NCT05243251** · PHASE3 · COMPLETED · sponsor: **Cairo University** · enrollment: 164 (actual)

## Conditions studied

- Anorexia

## Interventions

- **DRUG:** Olanzapine 5 MG
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05243251
- **Lead sponsor:** Cairo University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-12-25
- **Primary completion:** 2022-11-21
- **Final completion:** 2022-12-14
- **Target enrollment:** 164 (ACTUAL)
- **Last updated:** 2024-10-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05243251

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05243251, "Olanzapine Anorexia Cachexia". Retrieved via AI Analytics 2026-08-18 from https://api.ai-analytics.org/clinical/NCT05243251. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*